On the evening of October 21, Guangzhou Wondfo Biotech Co., Ltd. announced that its fifth board meeting convened on October 21, 2025, where it reviewed and approved a proposal regarding the non-adjustment of the conversion price for its convertible bonds. The board decided not to lower the conversion price of the "Wondfo Convertible Bonds" and stated that from the next trading day after this decision, for the following three months (from October 22, 2025, to January 21, 2026), if the conditions for lowering the conversion price are triggered again, no proposal for such a downward adjustment will be made. Starting from January 22, 2026, if the conditions for lowering the conversion price are triggered again, the board will hold another meeting to decide whether to exercise the right to lower the conversion price of the "Wondfo Convertible Bonds".
Comments